Immunotherapy successful against deadly breast cancer
A new trial confirms that a combination of immunotherapy and chemotherapy boosts survival rates for people with triple-negative breast cancer.
More... |
Re: Immunotherapy successful against deadly breast cancer
The new imunotherapy drug isnt really new. it is another PD1 inhibitor with a brand name of Tecentriq. My computer was down and I was a bit frustrated because I was curious about Tecentriq thinking it was something new. I printed out the package insert and will read it today but my educated guess is Opdivo or Keytruda added to the chemo would give the same results as Tecentriq. I hope Im wrong
Paul |
All times are GMT -7. The time now is 09:38 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021